The DEK protein-an abundant and ubiquitous constituent of mammalian chromatin

Gene

Volumn 343, Issue 1, 2004, Pages 1-9

  Waldmann, Tanja ^a   Scholten, Ingo ^a   Kappes, Ferdinand ^a   Hu, Hong Gang ^a   Knippers, Rolf ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

Architectural chromatin protein; DNA binding; HMG protein; Leukemia; Supercoiling

Indexed keywords

NUCLEAR PROTEIN; PROTEIN DEK; UNCLASSIFIED DRUG;

BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CELL FRACTIONATION; CELL PROLIFERATION; CHROMATIN; DNA BINDING; DNA HELIX; DNA SEQUENCE; GENE MUTATION; HUMAN; LEUKEMIA; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CHROMATIN; CHROMOSOMAL PROTEINS, NON-HISTONE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 6; HIGH MOBILITY GROUP PROTEINS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NUCLEOPROTEINS; ONCOGENE PROTEINS; ONCOGENES; TRANSLOCATION, GENETIC;

MAMMALIA;

EID: 9244264390     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gene.2004.08.029     Document Type: Review

References (55)

1. B.S. Adams, H.C. Cha, J. Cleary, T. Haiying, H. Wang, K. Sitwala, and D.M. Markovitz DEK binding to class II MHC Y-box sequences is gene- and allele-specific Arthritis Res. Ther. 5 2003 R226 R233
2. A. Agresti, and M.E. Bianchi HMGB proteins and gene expression Curr. Opin. Genet. Dev. 13 2003 170 178
3. V. Alexiadis, T. Waldmann, J. Andersen, M. Mann, R. Knippers, and C. Gruss The protein encoded by the proto-oncogene DEK changes the topology of chromatin and reduces the efficiency of DNA replication in a chromatin- specific manner Genes Dev. 14 2000 1308 1312
4. L. Aravind, and E.V. Koonin SAP-a putative DNA-binding motif involved in chromosomal organization Trends Biochem. Sci. 25 2000 112 114
5. J. Boer, J. Bonten-Surtel, and G. Grosveld Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis Mol. Cell. Biol. 18 1998 1236 1247
6. M. Bustin Chromatin unfolding and activation by HMGN(*) chromosomal proteins Trends Biochem. Sci. 26 2001 431 437
7. M. Campillos, M.A. Garcia, F. Valdivieso, and J. Vazquez Transcriptional activation by AP-2alpha is modulated by the oncogene DEK Nucleic Acids Res. 31 2003 1571 1575
8. X. Dong, M.A. Michelis, J. Wang, R. Bose, T. DeLange, and W.H. Reeves Autoantibodies to DEK oncoprotein in a patient with systemic lupus erythematosus and sarcoidosis Arthritis Rheum. 41 1998 1505 1510
9. X. Dong, J. Wang, F.N. Kabir, M. Shaw, A.M. Reed, L. Stein, L.E. Andrade, V.F. Trevisani, M.L. Miller, T. Fujii, M. Akizuki, L.M. Pachman, M. Satoh, and W.H. Reeves Autoantibodies to DEK oncoprotein in human inflammatory disease Arthritis Rheum. 43 2000 85 93
10. M. Fornerod, J. Boer, S. van Baal, M. Jaegle, M. von Lindern, K.G. Murti, D. Davis, J. Bonten, A. Buijs, and G. Grosveld Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements Oncogene 10 1995 1739 1748
11. G.K. Fu, G. Grosveld, and D.M. Markovitz DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer Proc. Natl. Acad. Sci. U. S. A. 94 1997 1811 1815
12. K.D. Grasser, S.H. Teo, K.B. Lee, R.W. Broadhurst, C. Rees, C.H. Hardman, and J.O. Thomas DNA-binding properties of the tandem HMG boxes of high-mobility-group protein 1 (HMG1) Eur. J. Biochem. 253 1998 787 795
13. C. Grottke, K. Mantwill, M. Dietel, D. Schadendorf, and H. Lage Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs Int. J. Cancer 88 2000 535 546
14. C. Gruss, and R. Knippers The SV40 Minichromosome Methods Mol. Genet. 7 1995 101 114
15. B. Guerra, and O.G. Issinger Protein kinase CK2 and its role in cellular proliferation, development and pathology Electrophoresis 20 1999 391 408
16. H. Hamaguchi, K. Nagata, K. Yamamoto, I. Fujikawa, M. Kobayashi, and M. Eguchi Establishment of a novel human myeloid leukaemia cell line (FKH-1) with t(6;9)(p23;q34) and the expression of dek-can chimaeric transcript Br. J. Haematol. 102 1998 1249 1256
17. A.D. Hollenbach, C.J. McPherson, E.J. Mientjes, R. Iyengar, and G. Grosveld Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek J. Cell. Sci. 115 2002 3319 3330
18. K. Javaherian, J.F. Liu, and J.C. Wang Nonhistone proteins HMG1 and HMG2 change the DNA helical structure Science 199 1978 1345 1346
19. F. Kappes, K. Burger, M. Baack, F.O. Fackelmayer, and C. Gruss Subcellular localization of the human protooncogene protein DEK J. Biol. Chem. 276 2001 26317 26323
20. F. Kappes, C. Damoc, R. Knippers, M. Przybylski, L.A. Pinna, and C. Gruss Phosphorylation by Protein Kinase CK2 Changes the DNA Binding Properties of the Human Chromatin Protein DEK Mol. Cell. Biol. 24 2004 6011 6020
21. F. Kappes, I. Scholten, N. Richter, C. Gruss, and T. Waldmann Functional domains of the ubiquitous chromatin protein DEK Mol. Cell. Biol. 24 2004 6000 6010
22. M. Kipp, F. Gohring, T. Ostendorp, C.M. van Drunen, R. van Driel, M. Przybylski, and F.O. Fackelmayer SAFBox, a conserved protein domain that specifically recognizes scaffold attachment region DNA Mol. Cell. Biol. 20 2000 7480 7489
23. N. Kondoh, T. Wakatsuki, A. Ryo, A. Hada, T. Aihara, S. Horiuchi, N. Goseki, O. Matsubara, K. Takenaka, M. Shichita, K. Tanaka, M. Shuda, and M. Yamamoto Identification and characterization of genes associated with human hepatocellular carcinogenesis Cancer Res. 59 1999 4990 4996
24. D. Kraemer, R.W. Wozniak, G. Blobel, and A. Radu The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm Proc. Natl. Acad. Sci. U. S. A. 91 1994 1519 1523
25. A. Krithivas, M. Fujimuro, M. Weidner, D.B. Young, and S.D. Hayward Protein interactions targeting the latency-associated nuclear antigen of kaposi's sarcoma-associated herpesvirus to cell chromosomes J. Virol. 76 2002 11596 11604
26. R.A. Kroes, A. Jastrow, M.G. McLone, H. Yamamoto, P. Colley, D.S. Kersey, V.W. Yong, E. Mkrdichian, L. Cerullo, J. Leestma, and J.R. Moskal The identification of novel therapeutic targets for the treatment of malignant brain tumors Cancer Lett. 156 2000 191 198
27. M.L. Larramendy, T. Niini, E. Elonen, B. Nagy, J. Ollila, M. Vihinen, and S. Knuutila Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia, A microarray analysis Haematologica 87 2002 569 577
28. H. Le Hir, E. Izaurralde, L.E. Maquat, and M.J. Moore The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions EMBO J. 19 2000 6860 6869
29. H. Le Hir, D. Gatfield, E. Izaurralde, and M.J. Moore The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay EMBO J. 20 2001 4987 4997
30. F. Lejeune, Y. Ishigaki, X. Li, and L.E. Maquat The exon junction complex is detected on CBP80-bound but not eIF4E- bound mRNA in mammalian cells: dynamics of mRNP remodeling EMBO J. 21 2002 3536 3545
31. D.W. Litchfield Protein kinase CK2: structure, regulation and role in cellular decisions of life and death Biochem. J. 369 2003 1 15
32. J. Lykke-Andersen, M.D. Shu, and J.A. Steitz Communication of the position of exon-exon junctions to the mRNA surveillance machinery by the protein RNPS1 Science 293 2001 1836 1839
33. T. McGarvey, E. Rosonina, S. McCracken, Q. Li, R. Arnaout, E. Mientjes, J.A. Nickerson, D. Awrey, J. Greenblatt, G. Grosveld, and B.J. Blencowe The acute myeloid leukemia-associated protein, DEK, forms a splicing- dependent interaction with exon-product complexes J. Cell Biol. 150 2000 309 320
34. F. Meggio, and L.A. Pinna One-thousand-and-one substrates of protein kinase CK2? FASEB J. 17 2003 349 368
35. M.S. Meyn, J.M. Lu-Kuo, and L.B. Herzing Expression cloning of multiple human cDNAs that complement the phenotypic defects of ataxia-telangiectasia group D fibroblasts Am. J. Hum. Genet. 53 1993 1206 1216
36. M.S. Nissen, and R. Reeves Changes in superhelicity are introduced into closed circular DNA by binding of high mobility group protein I/Y J. Biol. Chem. 270 1995 4355 4360
37. R. Reeves Molecular biology of HMGA proteins: hubs of nuclear function Gene 277 2001 63 81
38. R. Reeves HMGA proteins: flexibility finds a nuclear niche? Biochem. Cell. Biol. 81 2003 185 195
39. R. Reeves, and L. Beckerbauer HMGI/Y proteins: flexible regulators of transcription and chromatin structure Biochim. Biophys. Acta 1519 2001 13 29
40. R. Reeves, and L. Beckerbauer HMGI/Y proteins: flexible regulators of transcription and chromatin structure Biochim. Biophys. Acta 1519 2001 13 29
41. V.L. Reichert, H. Le Hir, M.S. Jurica, and M.J. Moore 5' exon interactions within the human spliceosome establish a framework for exon junction complex structure and assembly Genes Dev. 16 2002 2778 2791
42. S. Sarno, H. Reddy, F. Meggio, M. Ruzzene, S.P. Davies, A. Donella-Deana, D. Shugar, and L.A. Pinna Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2') FEBS Lett. 496 2001 44 48
43. H. Savli, Y. Aalto, B. Nagy, S. Knuutila, and S. Pakkala Gene expression analysis of 1,25(OH)2D3-dependent differentiation of HL-60 cells: a cDNA array study Br. J. Haematol. 118 2002 1065 1070
44. Scholten, I. (2004). Charaterisation of the proto-oncoprotein DEK, doctoral thesis University of Konstanz.
45. H. Sierakowska, K.R. Williams, I.S. Szer, and W. Szer The putative oncoprotein DEK, part of a chimera protein associated with acute myeloid leukaemia, is an autoantigen in juvenile rheumatoid arthritis [published erratum appears in Clin Exp Immunol 1994 Apr;96(1):177] Clin. Exp. Immunol. 94 1993 435 439
46. K.V. Sitwala, K. Adams, and D.M. Markovitz YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter Oncogene 21 2002 8862 8870
47. C. Thiede, C. Steudel, B. Mohr, M. Schaich, U. Schakel, U. Platzbecker, M. Wermke, M. Bornhauser, M. Ritter, A. Neubauer, G. Ehninger, and T. Illmer Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis Blood 99 2002 4326 4335
48. J.O. Thomas HMG1 and 2: architectural DNA-binding proteins Biochem. Soc. Trans. 29 2001 395 401
49. J.O. Thomas, and A.A. Travers HMG1 and 2, and related 'architectural' DNA-binding proteins Trends Biochem. Sci. 26 2001 167 174
50. M. von Lindern, A. Poustka, H. Lerach, and G. Grosveld The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34 Mol. Cell. Biol. 10 1990 4016 4026
51. M. von Lindern, M. Fornerod, S. van Baal, M. Jaegle, T. de Wit, A. Buijs, and G. Grosveld The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA Mol. Cell. Biol. 12 1992 1687 1697
52. T. Waldmann, C. Eckerich, M. Baack, and C. Gruss The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils J. Biol. Chem. 277 2002 24988 24994
53. T. Waldmann, M. Baack, N. Richter, and C. Gruss Structure-specific binding of the proto-oncogene protein DEK to DNA Nucleic Acids Res. 31 2003 7003 7010
54. I. Wichmann, N. Respaldiza, J.R. Garcia-Lozano, M. Montes, J. Sanchez-Roman, and A. Nunez-Roldan Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE) Clin. Exp. Immunol. 119 2000 530 532
55. E. Zuckerkandl, and R. Villet Generation of high specificity of effect through low-specificity binding of proteins to DNA FEBS Lett. 231 1988 291 298